AMD STOPPER

STOP Macular Degeneration (AMD), $10 Million Investment

Facebook Twitter LinkedIn

AMD STOPPER has invented a new oral pharmaceutical formula which stops the progression of Age-related Macular Degeneration (AMD) and reverse symptoms.  Over 300 million patients worldwide have AMD which causes severe loss of central vision.  We are anxious to find the right partner that will share in providing a "cost effective" alternative for those plagued with this debilitating disease and provide solutions for future generations.
 
A major California Medical Center Ophthalmology Dept has recorded a patient having stopped the progression of AMD after taking a new oral pharmaceutical formula and, in his case, reversing some of the effects. This formula is a combination of already FDA approved vitamin, anti-inflammatory, and prescriptive elements which cannot be divulged until our patent and trademark are granted.
 
The first sign of ‘NO AMD PROGRESSION’ was detected 6 months after taking the formula once daily. AMD STOPPER, a new company, will bring this new formula to the market.
 
We are looking for assistance in bringing the product to the FDA for marketing clearance and to secure patent protection. We look forward to hearing from you.
 
James Kraushaar,
President
[email protected]

Please see attached AMD Prospectus 
 

Ready to Ask For Funding for your company?

Post a Funding Request

AMD STOPPER is no longer seeking funding.